SEC CIK 1365619
Brege Laura
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PCRXview stock → | 30,120 | 2026-06-10 |
| ACADview stock → | 23,202 | 2026-05-29 |
| DCTHview stock → | 11,678 | 2014-07-07 |
Position History — PCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-10 | Grant / award (derivative) | 10,891 | $0.00 | 10,891 |
| 2026-06-10 | Grant / award | 6,405 | $0.00 | 30,120 |
| 2025-06-11 | Grant / award (derivative) | 11,279 | $0.00 | 11,279 |
| 2025-06-11 | Grant / award | 6,163 | $0.00 | 23,715 |
| 2024-08-16 | Open-market buy | 1,000 | $12.81 | 17,552 |
| 2024-06-12 | Grant / award (derivative) | 12,179 | $0.00 | 12,179 |
| 2024-06-12 | Grant / award | 5,230 | $0.00 | 16,552 |
| 2023-06-14 | Grant / award (derivative) | 12,925 | $0.00 | 12,925 |
| 2023-06-14 | Grant / award | 1,775 | $0.00 | 11,322 |
| 2023-06-05 | Open-market sale | 600 | $38.74 | 9,547 |
| 2023-04-03 | Option exercise (derivative) | 7,000 | $0.00 | 0 |
| 2023-04-03 | Open-market sale | 7,000 | $40.72 | 10,147 |
| 2023-04-03 | Option exercise | 7,000 | $29.90 | 17,147 |
| 2022-06-08 | Grant / award (derivative) | 8,225 | $0.00 | 8,225 |
| 2022-06-08 | Grant / award | 1,160 | $0.00 | 10,147 |
| 2021-06-09 | Grant / award (derivative) | 7,626 | $0.00 | 7,626 |
| 2021-06-09 | Grant / award | 1,066 | $0.00 | 8,987 |
| 2020-11-16 | Option exercise (derivative) | 12,000 | $0.00 | 0 |
| 2020-11-16 | Open-market sale | 12,000 | $65.95 | 7,921 |
| 2020-11-16 | Option exercise | 12,000 | $13.98 | 19,921 |
| 2020-06-09 | Grant / award (derivative) | 8,027 | $0.00 | 8,027 |
| 2020-06-09 | Grant / award | 1,260 | $0.00 | 7,921 |
| 2020-06-05 | Open-market sale | 2,100 | $48.70 | 6,661 |
| 2019-06-05 | Grant / award (derivative) | 8,437 | $0.00 | 8,437 |
| 2019-06-05 | Grant / award | 4,134 | $0.00 | 8,761 |
| 2018-06-13 | Grant / award (derivative) | 4,693 | $0.00 | 4,693 |
| 2018-06-13 | Grant / award | 782 | $0.00 | 4,627 |
| 2017-06-14 | Grant / award (derivative) | 2,714 | $0.00 | 2,714 |
| 2017-06-14 | Grant / award | 1,357 | $0.00 | 3,845 |
| 2016-06-15 | Grant / award (derivative) | 2,975 | $0.00 | 2,975 |
| 2016-06-15 | Grant / award | 1,488 | $0.00 | 2,488 |
| 2016-06-06 | Open-market sale | 1,000 | $46.95 | 1,000 |
| 2015-06-03 | Grant / award (derivative) | 4,000 | $0.00 | 4,000 |
| 2015-06-03 | Grant / award | 2,000 | $0.00 | 2,000 |
| 2014-06-03 | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2014-05-09 | Option exercise (derivative) | 7,000 | $0.00 | 0 |
| 2014-05-09 | Option exercise (derivative) | 3,000 | $0.00 | 12,000 |
| 2014-05-09 | Option exercise | 3,000 | $13.98 | 10,000 |
| 2014-05-09 | Option exercise | 7,000 | $10.81 | 7,000 |
| 2014-05-09 | Open-market sale | 2,500 | $74.67 | 0 |
| 2014-05-09 | Open-market sale | 7,500 | $73.57 | 2,500 |
| 2013-06-12 | Grant / award (derivative) | 7,000 | $0.00 | 7,000 |
| 2012-06-05 | Grant / award (derivative) | 7,000 | $0.00 | 7,000 |
| 2011-06-02 | — | — | — | 0 |
| 2011-06-02 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.